Epilepsy and Menopause: What the Review Says About Treatment and Seizures
This explainer reviews what is known about epilepsy and menopause during the menopause transition.
Source: Neurology. Clinical practice
Summary
What was studied
This was a narrative review of existing information about epilepsy during perimenopause and menopause. It focused on how changing ovarian hormones and menopausal hormone therapy might affect seizure control and the metabolism of antiseizure medicines.
The review also discussed hormonal and nonhormonal treatments for menopause symptoms. The abstract does not report a participant group, a systematic search method, or new clinical trial data.
What they found
Menopause symptoms can negatively affect quality of life, including vasomotor and genitourinary symptoms, mood and sleep disturbances, and cognitive changes. Hormone therapy is described as the most effective treatment for menopause symptoms, but evidence about its use in women with epilepsy is limited. Hormone therapy may affect seizure control and the metabolism of some antiseizure medicines, including lamotrigine. The abstract does not state how often these effects occur or how large they may be.
Limits of the evidence
This is a narrative review rather than a new clinical study. The available evidence is described as limited, and data are largely lacking to guide epilepsy management during perimenopause and menopause. The abstract does not provide study sizes, specific hormone therapy formulations or doses, or comparisons between treatments.
For families and caregivers
Menopause symptoms can affect quality of life, while hormonal changes and treatments may be relevant to seizure control and antiseizure medication metabolism. The review discusses hormonal and nonhormonal options for menopause symptoms, but the limited evidence does not establish a single best approach for people with epilepsy. It specifically notes that hormone therapy may affect lamotrigine metabolism.
What to watch next
Further research is needed to clarify how perimenopause, menopause, hormone therapy, and nonhormonal treatments relate to seizure control and antiseizure medication metabolism, and to better guide epilepsy management during these stages.
Terms in this summary
- Perimenopause
- The reproductive stage marked by fluctuating ovarian estrogen and progesterone production before menopause.
- Menopause
- The reproductive stage associated with permanent loss of ovarian estrogen and progesterone production.
- Menopausal hormone therapy
- Hormone-based treatment used to manage menopause symptoms.
- Antiseizure medication
- Medicine used to prevent or reduce seizures.
- Metabolism
- How the body processes a medicine, which can influence its effects.
- Lamotrigine
- An antiseizure medicine whose metabolism may be affected by hormone therapy.
- Vasomotor symptoms
- Menopause symptoms related to changes in temperature regulation.
- Genitourinary symptoms
- Menopause symptoms affecting the genital and urinary systems.
Free: Seizure First Aid Quick Guide (PDF)
Plus one plain-language weekly digest of new epilepsy research.
Unsubscribe anytime. No medical advice.